Skip to main content

Animations

MJFF Publications

2401 - 2410 of 6509 Results
Title
Year
  • Year
  • 2014
  • 2014
  • 2014
  • 2013
  • 2010
  • 2018
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Barriers to investigator-initiated deep brain stimulation and device research
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000345
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Naltrexone for impulse control disorders in Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000000729
    Citation Count: 90
  • Summary Details
    OPEN
    Title: Reorganization of corticostriatal circuits in healthy G2019S LRRK2 carriers
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000001189
    Citation Count: 76
  • Summary Details
    OPEN
    Title: Isolation of Murine Postnatal Brain Microglia for Phenotypic Characterization Using Magnetic Cell Separation Technology
    Journal Name: Methods in Molecular Biology
    Publisher: Humana Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/978-1-62703-520-0_5
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Maladaptive striatal plasticity in l-DOPA-induced dyskinesia
    Journal Name: Progress in Brain Research
    Publisher: Elsevier
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s0079-6123(10)83011-0
    Citation Count: 198
  • Using Molecular Tweezers to Remodel Abnormal Protein Self-Assembly and Inhibit the Toxicity of Amyloidogenic Proteins
    2018
    Summary Details
    OPEN
    Title: Using Molecular Tweezers to Remodel Abnormal Protein Self-Assembly and Inhibit the Toxicity of Amyloidogenic Proteins
    Journal Name: Methods in Molecular Biology
    Publisher: Springer New York
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/978-1-4939-7811-3_24
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation Study
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-202487
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and Falling
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-212636
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasound
    Journal Name: Oncotarget
    Publisher: Impact Journals, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.18632/oncotarget.28139
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Systematic analysis of PINK1 variants of unknown significance shows intact mitophagy function for most variants
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00258-8
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.